Slingshot members are tracking this event:
New business venture focused on generics in Japan to be established in or after April 2016; owned 51% by Teva and 49% by Takeda
Slingshot Insights Explained
Apr 01, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Blopress, Takepron, Basen, Japan, Generics